Concepedia

Helene Sieberer

HS

Statistics

Publications

2

Citations

24

H-Index

2

Active since

2023

Affiliations

Institute for Biomedicine(Current)

Paracelsus Medical University

University of Salzburg

Eurac Research

University of Applied Sciences Upper Austria

Helene Sieberer is an author at Institute for Biomedicine specializing in cell biology, innate immunity, and apoptosis in cancer.

Publications per year

2023–2024

2

Publications

2

The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells

Laura Urwanisch, Michael S. Unger, Helene Sieberer et al. · Cancers · 2023 · 13 citations · Full text

, , +17

Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosis

Michela Luciano, Helene Sieberer, Peter W. Krenn et al. · Cell Communication and Signaling · 2024 · 11 citations · Full text

, , +17

1–2 of 2